Literature DB >> 32146696

Design strategy of optical probes for tumor hypoxia imaging.

Fengfeng Xue1, Jufeng Chen1,2, Hangrong Chen3.   

Abstract

Clinical manifestations of tumors indicate that malignant phenotypes developing in the hypoxic microenvironment lead to resistance to cancer treatment, rendering chemotherapy, radiotherapy, and photodynamic therapy less sensitive and effective in patients with tumor. Visualizing the oxygen level in the tumor environment has garnered much attention due to its implications in precision tumor therapy. Following the rapid development of biomaterials in nanotechnology, various nanomaterials have been designed to visualize the oxygen levels in tumors. Here, we review recent research on detecting oxygen levels in solid tumors for tumor hypoxia imaging. To monitor the hypoxic level of tumors, two main strategies were investigated: directly detecting oxygen levels in tumors and monitoring the hypoxia-assisted reduced microenvironment. We believe that hypoxia as a tumor-specific microenvironment can be a breakthrough in the clinical treatment of tumors.

Entities:  

Keywords:  fluorescent imaging; hypoxia probes; hypoxia sensing; tumor hypoxia

Year:  2020        PMID: 32146696     DOI: 10.1007/s11427-019-1569-4

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  62 in total

Review 1.  Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell.

Authors:  P I Bastiaens; A Squire
Journal:  Trends Cell Biol       Date:  1999-02       Impact factor: 20.808

Review 2.  Exploiting tumour hypoxia in cancer treatment.

Authors:  J Martin Brown; William R Wilson
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

Review 3.  Fluorescence lifetime imaging--techniques and applications.

Authors:  W Becker
Journal:  J Microsc       Date:  2012-05-24       Impact factor: 1.758

Review 4.  Fluorescence lifetime measurements and biological imaging.

Authors:  Mikhail Y Berezin; Samuel Achilefu
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

5.  The tumor microenvironment at a glance.

Authors:  Frances R Balkwill; Melania Capasso; Thorsten Hagemann
Journal:  J Cell Sci       Date:  2012-12-01       Impact factor: 5.285

Review 6.  The tumour microenvironment as a target for chemoprevention.

Authors:  Adriana Albini; Michael B Sporn
Journal:  Nat Rev Cancer       Date:  2007-02       Impact factor: 60.716

Review 7.  Dendritic cells as therapeutic vaccines against cancer.

Authors:  Jacques Banchereau; A Karolina Palucka
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

Review 8.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

9.  MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.

Authors:  Paul Cao; Zhiyong Deng; Meimei Wan; Weiwei Huang; Scott D Cramer; Jianfeng Xu; Ming Lei; Guangchao Sui
Journal:  Mol Cancer       Date:  2010-05-17       Impact factor: 27.401

Review 10.  Tumor hypoxia and the progression of prostate cancer.

Authors:  Aristotelis G Anastasiadis; Brian C Stisser; Mohamed A Ghafar; Martin Burchardt; Ralph Buttyan
Journal:  Curr Urol Rep       Date:  2002-06       Impact factor: 2.862

View more
  2 in total

Review 1.  Significance of Specific Oxidoreductases in the Design of Hypoxia-Activated Prodrugs and Fluorescent Turn off-on Probes for Hypoxia Imaging.

Authors:  Ewelina Janczy-Cempa; Olga Mazuryk; Agnieszka Kania; Małgorzata Brindell
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

2.  A brief introduction to biophotonic techniques and methods.

Authors:  Qingming Luo
Journal:  Sci China Life Sci       Date:  2020-12-01       Impact factor: 6.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.